Ross Stores raises 2026 earnings guidance after Q2 double beat
Ross Stores reported second-quarter revenue of $6.27 billion and earnings of $2.66 per share, both above estimates, and lifted 2026 earnings guidance to $8.61-$8.77 per share.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Ross Stores reported second-quarter revenue of $6.27 billion and earnings of $2.66 per share, both above estimates, and lifted 2026 earnings guidance to $8.61-$8.77 per share.
$MRK Merck & Co Q2 Earnings
() -- Healthcare stocks were declining premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.6% and the iShares Biotechnology ETF (IBB) 0.1% lower. Elevance Health (ELV) shares were down more than 8% after the company reported lower Q2 adjusted earnings. Johnson & Johnson (JNJ) stoc
() -- Biopharma pricing power will be the key swing factor for Q2 earnings as companies with cleaner growth outlooks continue to outperform peers facing loss-of-exclusivity headwinds, Bank of America said in a note Friday. Merck & Co (MRK), AbbVie (ABBV), Jazz Pharmaceuticals (JAZZ) and Ionis Pharmaceuticals (IONS) rem